Tango Therapeutics, Inc. (TNGX) Misses Q2 EPS by 5c

Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q2 EPS of ($0.37), $0.05 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Raymond James Reiterates Underperform Rating on Lennar (LEN)
• Trump approval falls to 32%, lowest ever - Reuters/Ipsos Poll